Statistics

Total Visits

Views
GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutati64

Select a period of time:

Number of views in the range

Views
GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutati30

Views

Views
July 202517
August 20250
September 20253
October 20250
November 20256
December 20253
January 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Brazil10
Ecuador2
Argentina2
Germany1
Italy1
Panama1
Portugal1
Venezuela1
South Africa1
 

Top cities views

Views
Guayaquil2
Almada1
Campinas1
Cape Town1
Caçapava1
Curitiba1
Dallas1
Edmonton1
Fazenda Rio Grande1
Frankfurt am Main1